Sign In
Buy PBH
$50.22
+0.270 (+0.541%)
At Close: Jul 31, 2026
Prestige Consumer Healthcare Inc (PBH) CEO Ronald M. Lombardi Sold $–.— million of Shares
12:00am, Wednesday, 13'th May 2020Analysts Have Made A Financial Statement On Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Annual Report
12:08pm, Monday, 11'th May 2020
Prestige Consumer Healthcare Inc. (NYSE:PBH) last week reported its latest annual results, which makes it a good time...
The osteoarthritis therapeutics market size has the potential to grow by USD 2.99 billion during 2020-2024
Prestige Consumer Healthcare Inc (PBH) Q4 2020 Earnings Call Transcript
11:00pm, Thursday, 07'th May 2020
On the call with me today are Ron Lombardi, our Chairman, President and CEO; and Chris Sacco, our CFO. On today's call, we'll begin with some topical remarks, given the current crisis, review the res
Prestige Consumer (PBH) Q4 Earnings & Revenues Top Estimates
03:12pm, Thursday, 07'th May 2020
Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
02:05pm, Thursday, 07'th May 2020
Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer Q4 EPS $0.820 Beats $0.740 Estimate, Sales $251.235M Beat $239.840M Estimate
10:52am, Thursday, 07'th May 2020Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results
10:00am, Thursday, 07'th May 2020
Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1.
Karuna Therapeutics Reports First Quarter 2020 Financial Results and Provides General Business Update
12:00am, Thursday, 07'th May 2020
Karuna Therapeutics, Inc. (Nasdaq: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the pote
The allergy rhinitis drugs market size has the potential to grow by USD 2.4 billion during 2020-2024
Ipsen enters into an option agreement with IRICoR and Université de Montréal for a discovery-stage oncology program
12:00am, Monday, 04'th May 2020
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian research commercializati
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
04:34pm, Thursday, 30'th Apr 2020
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
04:34pm, Thursday, 30'th Apr 2020
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks: Analysts Expect Prestige Consumer Healthcare Inc (NYSE:PBH) to Announce $0.74 Earnings Per Share
10:36am, Thursday, 30'th Apr 2020
Wall Street brokerages expect Prestige Consumer Healthcare Inc (NYSE:PBH) to announce $0.74 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts ha
